Xingqi Pharmaceutical's first-half net profit rises 28.55% year on year, plans dividend of 3 yuan per 10 shares

证券时报··CN·Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Xingqi Pharmaceutical disclosed its interim report on August 27. In the first half of 2026, it achieved operating revenue of 1.401 billion yuan, up 20.48% year on year. Net profit attributable to shareholders of the listed company was 430 million yuan, up 28.55% year on year, with basic earnings per share of 1.2 yuan. The company plans to distribute a cash dividend of 3 yuan, tax included, for every 10 shares.

Impact on assets 1

Others▲ · 1 stocks
© 2026 MarketIVNews